Why the study?
Target blood pressure levels below 130/80 mmHg demand multiple drug combinations, making rational triple fixed combinations highly relevant under updated European guidelines.
Does triple fixed-dose combination therapy improve blood pressure control and adherence in patients with arterial hypertension compared to free-dose combinations?
Does triple fixed-dose combination therapy improve blood pressure control and adherence in patients with arterial hypertension compared to free-dose combinations?
The 2018 ESC/ESH guidelines strongly support the use of single-pill triple fixed-dose combinations to improve adherence and achieve stricter blood pressure targets in hypertension management.
Answers are grounded in this paper and cite their sources.
May encourage fixed-dose combinations per 2018 guidelines; leaves open randomized trials on triple therapy vs free combinations.
The majority of patients with stable arterial hypertension require combination therapy which is supported by the clinical evidence. The established target levels of blood pressure below 130/80 mmHg are challenging and demand multiple drug combinations in a single patient. Therefore, the use of dual and triple combination therapy is getting wider, and rational triple fixed combinations are highly relevant. The updated guidelines on the diagnostics, management and treatment of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology confirm and recommend early and wider use of the fixed-dose drug combinations. The paper reviews the main practical issues of the use of combination therapy, including key questions of the change from free dose to fixed dose combinations and their rational choice.
No takes yet. Share an insight, caveat, or question.
А. О. Конради (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: